Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (3): 383-386    DOI: 10.12891/ceog4112.2018
Original Research Previous articles | Next articles
Cantharidin is superior to trichloroacetic acid for the treatment of non-mucosal genital warts: a pilot randomized controlled trial
M.A. Recanati1, *(), K.J. Kramer1, J.J. Maggio1, C.R. Chao1
1 Wayne State University, C.S. Mott Center for Human Growth and Development, Detroit MI, USA
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Condyloma acuminatum is a sexually transmitted viral disease caused by the human papillomavirus (HPV). It is the most common viral sexually transmitted disease. In this randomized controlled trial, cantharidin was found to be more effective and better tolerated than trichloro-acetic acid (TCA) for the treatment of these lesions. Patients treated with cantharidin healed with less scarring than those treated with TCA (p < 0.034), had less pain during treatment (p < 0.01), and required fewer treatments to eradicate warts (p < 0.01) when compared to trichloroacetic acid.
Key words:  Condyloma acuminatum      Human papillomavirus      Cantharidin      Trichloroacetic acid     
Published:  10 June 2018     
*Corresponding Author(s):  M.A. RECANATI     E-mail:  marecanati@gmail.com

Cite this article: 

M.A. Recanati, K.J. Kramer, J.J. Maggio, C.R. Chao. Cantharidin is superior to trichloroacetic acid for the treatment of non-mucosal genital warts: a pilot randomized controlled trial. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 383-386.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4112.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I3/383

No related articles found!
No Suggested Reading articles found!